Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Arthritis Research & Therapy
Hisashi YamanakaSamuel H Zwillich

Abstract

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Here, tofacitinib safety and efficacy data from a long-term extension study in Japanese patients are presented. Study A3921041 was a multi-centre, open-label, long-term extension study that included Japanese patients who had participated in a prior Phase 2 or Phase 3 study of tofacitinib as monotherapy or with background methotrexate. Patients received tofacitinib 5 mg twice daily (BID) or tofacitinib 10 mg BID. Dose adjustment of tofacitinib during treatment period, and concomitant usage of disease-modifying antirheumatic drugs including methotrexate after week 12 were permitted. Primary endpoints were adverse events, laboratory parameters and vital signs. Secondary efficacy endpoints included American College of Rheumatology (ACR)20/50/70 response rates, Disease Activity Score (DAS)28-4(erythrocyte sedimentation rate (ESR))<2.6 response rate (DAS-defined remission) and Health Assessment Questionnaire-Disability Index (HAQ-DI) score. Safety and efficacy data were assessed throughout the study. A total of 486 patients were recruited and treated (1439.9 patient-years of exposure). 308 patients completed the study. Median (range) duration of ...Continue Reading

References

Oct 20, 1998·Arthritis and Rheumatism·A M van GestelP L van Riel
Feb 21, 2006·World Journal of Gastroenterology : WJG·Katherine D Crew, Alfred I Neugut
Apr 25, 2006·Modern Rheumatology·Nobuyuki MiyasakaKatsumi Eguchi
Aug 4, 2009·Autoimmunity Reviews·Francesca Bobbio PallaviciniCarlomaurizio Montecucco
Oct 27, 2009·Journal of Medical Virology·Nozomu ToyamaUNKNOWN Society of the Miyazaki Prefecture Dermatologists
Mar 20, 2010·Annals of the Rheumatic Diseases·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG)
Nov 26, 2010·Seminars in Arthritis and Rheumatism·Loreto CarmonaUNKNOWN EMECAR Study Group
Aug 10, 2012·The New England Journal of Medicine·Roy FleischmannUNKNOWN ORAL Solo Investigators
Aug 10, 2012·The New England Journal of Medicine·Ronald F van VollenhovenUNKNOWN ORAL Standard Investigators
Jun 19, 2014·The New England Journal of Medicine·Eun Bong LeeUNKNOWN ORAL Start Investigators
Jun 20, 2014·Arthritis & Rheumatology·Kevin L WinthropRichard Riese
Feb 5, 2015·Modern Rheumatology·Ayako NakajimaHisashi Yamanaka

❮ Previous
Next ❯

Citations

Nov 9, 2016·Current Opinion in Immunology·Kiyoshi HiraharaJohn J O'Shea
May 4, 2017·The New England Journal of Medicine·William J SandbornUNKNOWN OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators
Feb 2, 2017·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Oswaldo M CastañedaRicardo Rojo
Sep 25, 2017·Arthritis Care & Research·Xavier MarietteMary G Boy
Nov 7, 2017·Nature Reviews. Drug Discovery·Daniella M SchwartzJohn J O'Shea
Nov 16, 2017·Drugs·Sohita Dhillon
Oct 5, 2018·Expert Review of Clinical Immunology·Agnès Fernández-ClotetJulián Panés
Nov 15, 2018·Chinese Medical Journal·Zhan-Guo LiQi-Zhe Wu
Jan 16, 2019·Expert Opinion on Investigational Drugs·Jorge Ocampo-GarzaAntonella Tosti
May 26, 2018·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Paul BirdKrishan Thirunavukkarasu
Sep 13, 2019·Journal of Clinical Pharmacology·Misaki SuzukiSriram Krishnaswami
May 20, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kunihiro Yamaoka
Mar 20, 2019·Rheumatology International·Kenji Oku, Tatsuya Atsumi
Jul 14, 2020·Therapeutic Advances in Musculoskeletal Disease·Flavia SunziniStefan Siebert
May 23, 2020·Clinical and Experimental Gastroenterology·Edoardo TronconeGiovanni Monteleone
Jun 18, 2019·Therapeutic Advances in Gastroenterology·Ferdinando D'AmicoSilvio Danese
Jul 3, 2019·Case Reports in Rheumatology·Georgio MedawarRabih Said

❮ Previous
Next ❯

Methods Mentioned

BETA
ESR

Clinical Trials Mentioned

NCT00661661
NCT00687193
NCT00603512
NCT00847613

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.